NCT02866149View on ClinicalTrials.gov

Analysis of Circulating Tumor Markers in the Blood (ALCINA)

NACompletedINTERVENTIONAL
Enrollment

682

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2024

Study Completion Date

September 30, 2024

Conditions
Cancer
Interventions
BIOLOGICAL

Blood sampling

Up to 5 blood samplings can be performed at different time points

PROCEDURE

Tumor sampling

One tumor sampling can be performed, if applicable

OTHER

Stool sampling

Up to 5 blood samplings can be performed at different time points

Trial Locations (5)

21079

Centre Georges François Leclerc, Dijon

34298

Institut du Cancer de Montpellier, Montpellier

75005

Institut Curie (Paris hospital), Paris

75014

Institut Mutualiste Montsouris, Paris

92210

Institut Curie (St Cloud hospital), Saint-Cloud

All Listed Sponsors
lead

Institut Curie

OTHER

NCT02866149 - Analysis of Circulating Tumor Markers in the Blood (ALCINA) | Biotech Hunter | Biotech Hunter